Matching slides 3,748
Current window 2,851-2,880
Pages 125
Rows per page 30
Beat: Problem Agitate Solution Problem Identify Painclear collectionreset all

Beat

2,851-2,880 of 3,748

filter-aware
05
The diagram shows a circular, inefficient optimization process (affinity, developability, toxicity) leading to suboptimal candidates.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a comparison framework to contrast the data availability between small molecule and biologic drug discovery.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
02
Includes a hub-and-spoke diagram illustrating the effects of pathogenic autoantibodies.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Problem Identification1 hit
01
Slide 1
BenevolentAI | Investor Conference Presentation Deck | 17 slidesBenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
02
BenevolentAI | Investor Conference Presentation Deck | 17 slidesBenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
03
BenevolentAI | Investor Conference Presentation Deck | 17 slidesBenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
04
BenevolentAI | Investor Conference Presentation Deck | 17 slidesBenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
01
Slide 1
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
02
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
03
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
04
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
03
The slide uses a comparison of protein structures to explain the mechanism of action for the therapeutic candidate.Larimar Therapeutics | Results Presentation Deck | 15 slides · Larimar Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The chart uses a logarithmic scale on the y-axis to show the exponential decay of efficiency over time.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide highlights the divergence between technological progress in computing and the stagnation in pharmaceutical R&D productivity.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a classic 'before-after' or 'gap' framing by contrasting two opposing trends to justify the company's existence.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
01
Slide 1
Sarissa Capital | Activist Presentation Deck | 109 slidesSarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
02
Includes a timeline of regulatory/market events and a bar chart of historical revenue.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
03
Uses a contrast-pairs framework to highlight the divergence in business performance across regions.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
04
Sarissa Capital | Activist Presentation Deck | 109 slidesSarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
05
This slide serves as a track record or 'proof of competence' for the activist investor.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
06
Includes specific voting instructions and a call to action for a proxy contest.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
07
Sarissa Capital | Activist Presentation Deck | 109 slidesSarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
08
Includes NEJM citation and NNT (Number Needed to Treat) calculation.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
09
The slide uses a line chart to show mortality trends and a bar chart to show commercial success of blockbuster drugs.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
10
Uses a visual metaphor of a meat grinder to represent value destruction.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · Problem1 hit
11
The slide uses a large red arrow to emphasize the negative financial performance.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a visual gap analysis to emphasize the divergence between the company's stock and the broader sector index.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a before-after comparison to illustrate the scale of the acquisition.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
08
The table highlights accretion in both Revenue/Share and Adjusted EBITDA/Share.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
05
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit